Published on 3 Jan 2013
In a single year, there are 200-300 million cases of malaria and 50-100 million cases of dengue fever worldwide. So: Why haven’t we found a way to effectively kill mosquitoes yet? Hadyn Parry presents a fascinating solution: genetically engineering male mosquitoes to make them sterile, and releasing the insects into the wild, to cut down on disease-carrying species.
TED Talk Link
“And that’s exactly where we are. So this is technology that was developed in Oxford University a few years ago. The company itself, Oxitec, we’ve been working for the last 10 years, very much on a sort of similar development pathway that you’d get with a pharmaceutical company. So about 10 years of internal evaluation, testing, to get this to a state where we think it’s actually ready. And then we’ve gone out into the big outdoors, always with local community consent, always with the necessary permits. So we’ve done field trials now in the Cayman Islands, a small one in Malaysia, and two more now in Brazil…
We can produce them, in a space a bit more than this red carpet, I can produce about 20 million a week. We can transport them around the world. It’s not very expensive, because it’s a coffee cup — something the size of a coffee cup will hold about three million eggs. So freight costs aren’t our biggest problem. (Laughter) So we’ve got that. You could call it a mosquito factory. And for Brazil, where we’ve been doing some trials, the Brazilian government themselves have now built their own mosquito factory, far bigger than ours, and we’ll use that for scaling up in Brazil.“
A company producing GM mosquitoes says it is to open a new factory in Brazil as it expand its operations.
Small-scale studies in parts of Brazil, Panama and the Cayman Islands suggest engineered sterile mosquitoes can reduce wild insect populations by more than 90% when released into the wild.
Intrexon said the facility in Piraciciba, São Paulo, will be able to protect 300,000 people.
Aedes aegypti mosquitoes carry three viruses – Dengue, Zika and Chikungunya.
The studies were carried out by the only company currently trialling GM insects, Oxitec, based in Abingdon, Oxfordshire.
Oxitec, which was spun out from the University of Oxford, was bought by US company Intrexon for $160m (£106m) in August last year.
Oxitec CEO Hadyn Parry said: ” As the principal source for the fastest growing vector-borne infection in the world in Dengue fever, as well as the increasingly challenging Zika virus, controlling the Aedes aegypti population provides the best defence against these serious diseases for which there are no cures.”
Note: “…fastest growing vector infection”? Captain Parry of corporate pirate ship Oxitec, states he will find the solution now we have a problem. Any shares for sale Captain Parry? Still private, ground floor oppurtunity investor, climb aboard.
Published on May 26, 2014
Andrew Hessel designs synthetic viruses and uses the latest 3D printing technology to create medicine that is designed individually for a single patient. The promise here is that once he succeeds to design a synthetic virus that is able to penetrate the medicine throughout the body of the patient, he can scale the solution and present the world an almost free and much more capable medicine against cancer.
Synthetic biology…it’s genetic engineering done with digital tools.
…You do all you genetic design on a computer and then there’s this brilliant machine called a synthesiser that prints out that DNA.
You put that DNA into a cell and you can make it do damn near anything fuel, drugs, enzymes, biochemicals
…cancer-breaking virus…actually using cancer cells to make the drug that kills them…”
Note: The ability to engineer or manipulate bacteria and viruses are boastfully stated as common practise, as well as being relatively cheap.
You can see how GcMAF totally destroys this embroynic pharma niche. A natural safe method undermines the custom gene-splicers.
Uploaded on 3 Oct 2007
Dr. Rowen understands when to use allopathic, conventional, alternative, complimentary and oxidative medicine to help his patients heal and experience optimal health. Robert Rowen, MD, Editor Second Opinion Newsletter ozone, ultraviolet blood irradiation, hyperbaric oxygen valuable for healing and battle against microbial infections.